An AI-powered virtual reality program called MenoZen VRTM is being developed for menopause symptom management, addressing gaps in treatment accessibility according to research to be presented at The Menopause Society … Read More
Recent epidemiological research reveals a measurable biological association between higher exposure to bisphenol A (BPA)—a synthetic chemical widely used in plastics and resin linings—and elevated serum concentrations of key reproductive … Read More
Recent research published in August 2026 reveals that estrogen-only menopausal hormone therapy initiated in later life is associated with a lower risk of developing Alzheimer’s disease and related dementias. Conducted … Read More
Traditional pathological risk factors after prostate cancer surgery successfully identify patients with aggressive disease and worse prognoses, but they fail to predict who will benefit from adding hormone therapy to … Read More
Recent clinical investigations published in German media outlets evaluating testosterone dynamics reveal that regulated sexual activity correlates with statistically significant improvements in specific physical performance measurements. Led by endocrinological evaluations … Read More
Global medical experts are advocating for a formal renaming of Polycystic Ovary Syndrome (PCOS) to better reflect its systemic, multi-organ impact. In Plain English: The Clinical Takeaway The Case for … Read More
Female Gut Microbiomes and Hormones Are Rewriting IBS Diagnoses—Here’s What Patients Need to Know New research published this week in Nature Microbiology reveals that hormonal fluctuations and gut microbiome composition … Read More
A new study published this week in The American Journal of Psychiatry links hormonal contraceptives—specifically combined estrogen-progestin pills—to a statistically significant increase in binge eating disorder (BED) symptoms in 12% … Read More
Scientists have developed a light-activated molecular switch that selectively “wakes” dormant lung cancer cells, making them vulnerable to targeted therapies—potentially doubling treatment response rates in early-stage trials. The breakthrough, published … Read More
Recent data indicates that a significant percentage of patients prescribed GLP-1 receptor agonists for weight management or type 2 diabetes discontinue their medication within the first year of treatment. This … Read More
